MIST
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. (MIST) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 20, 2026.
- Industry:Biotechnology
- CEO:Joseph G. Oliveto
- Employees:38
- HQ:Montreal, QC, CA
- IPO:2019-05-09
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$82K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Oliveto JosephFirst filing | President and CEO | Sale | 36,500 | $82K | Apr 20 | SEC ↗ |
Related companies
Milestone Pharmaceuticals Inc. is in the Healthcare sector.